检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:徐伟 涂兵[1] XU Wei;TU Bing(Department of Hepatobiliary Surgery,The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
机构地区:[1]重庆医科大学附属第二医院肝胆外科,重庆400010
出 处:《临床肝胆病杂志》2020年第3期670-672,共3页Journal of Clinical Hepatology
摘 要:门静脉高压所致的胃-食管静脉曲张破裂出血及脾功能亢进等严重威胁到肝硬化患者的生命。目前外科断流术仍是治疗门静脉高压的重要术式之一,但药物、内镜及介入等治疗方式的兴起,使得断流术在门静脉高压治疗中的作用、手术指征、手术时机以及脾切除与否等受到争议。对断流术的作用及争议进行阐述分析,指出目前断流术仍是不可替代的,而门静脉高压的治疗应以个体化、综合性、微创为原则,尽可能带给患者最小的创伤、最大的受益。Gastroesophageal variceal bleeding and hypersplenism caused by portal hypertension seriously threaten the life of patients with liver cirrhosis.At present,devascularization is still one of the important surgical procedures for the treatment of portal hypertension;however,the development of the treatment methods such as drugs,endoscopy,and interventional treatment has caused the controversies over the role,surgical indications,and surgical timing of devascularization in the treatment of portal hypertension,as well as whether splenectomy is needed.This article reviews the role of devascularization and related controversies and points out that devascularization is still irreplaceable.Individualized,comprehensive,and minimally invasive treatment regimens should be developed for portal hypertension,so as to bring maximum benefits to patients with minimal invasiveness.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.137.222.1